Cancer- The breaking news on the treatment, cure and diagnosis of cancer

 
 

 
 

  • Search for "cancer news"
  • Depomed's Buy Rating Reiterated at Roth Capital

    Depomed's Buy Rating Reiterated at Roth Capital
    's stock had its "buy" rating restated by analysts at Roth Capital in a research report issued to clients and investors on Tuesday, AnalystRatings.Net reports. They presently have a $33.00 price objective on the specialty pharmaceutical company's stock.
  • Tweet was not meant to cause offence

    Tweet was not meant to cause offence
    "LEAST said, soonest mended," so they say. But you'll forgive me if I have just one bite of the cherry.
  • Kohler Original Recipe Chocolates Releases Limited Edition Flavor to Support Breast Cancer Awareness

    Kohler Original Recipe Chocolates Releases Limited Edition Flavor to Support Breast Cancer Awareness
    In honor of Breast Cancer Awareness Month, KOHLER Original Recipe Chocolates is releasing the limited edition Strawberry Balsamic Rare Facet for the second year to support the American Cancer Society. This delightful treat is a dark chocolate shell filled with a dark chocolate ganache of strawberry puree and aged, tart balsamic vinegar, handmade and airbrushed in a soft shade of pink by Kohler chocolatier, Anette Righi DeFendi.
  • Goodbye to the Master of Horror, Wes Craven

    Goodbye to the Master of Horror, Wes Craven
    To dig up some tabloid history for a footnote, Reynolds' "love rival" Elizabeth Taylor won the same humanitarian award in 1993. It sort of goes to show that everybody got theirs in that situation, except for Eddie Fisher.
  • Comedian Jeff Foxworthy, Ansley and Vicki Riedel Honored for Fighting Childhood Cancer

    Comedian Jeff Foxworthy, Ansley and Vicki Riedel Honored for Fighting Childhood Cancer
    At the same time, the company celebrated a major milestone, exceeding the who successfully petitioned Aflac to sponsor the Aflac Cancer Center in 1995, saw their footprints added to the Duckprints Wall of Fame at the Aflac Cancer Center. The event was hosted by national television sports commentator "It is an absolute fact that all the Aflac Cancer Center has become, and all it has come to mean to our Aflac family, the families we treat and its position as a national leader in the fight against childhood cancer, began with one tiny footprint - that of a 10-month-old baby girl diagnosed with an aggressive form of adult leukemia," Aflac Foundation President said.
  • Biocompare Cancer
  • Tilted Acoustic Tweezers Separate Cells Gently

    Tilted Acoustic Tweezers Separate Cells Gently
    Precise, gentle and efficient cell separation from a device the size of a cell phone may be possible thanks to tilt-angle standing surface acoustic waves, according to a team of engineers.
  • New Biomarker Highly Promising For Predicting Breast Cancer Outcomes

    New Biomarker Highly Promising For Predicting Breast Cancer Outcomes
    A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.
  • Finding Keys To Glioblastoma Therapeutic Resistance

    Finding Keys To Glioblastoma Therapeutic Resistance
    Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy. The answer lies not in the DNA sequence of the tumor, but in its epigenetic signature. These findings have been published online as a priority report in the journal Oncotarget.
  • Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs

    Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs
    A revolutionary new scientific method developed at the University of Leeds will improve the diversity of 'biologically active molecules', such as antibiotics and anti-cancer agents.
  • Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma

    Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma
    CINCINNATI - An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.